We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Combined Cytotoxic and Immune-Stimulatory Therapy for Glioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01811992
Recruitment Status : Completed
First Posted : March 15, 2013
Last Update Posted : August 31, 2021
Phase One Foundation
Information provided by (Responsible Party):
University of Michigan Rogel Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 2019
Actual Study Completion Date : January 2021